Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Medical Isotope Market, by Type
1.4.2 LAMEA Medical Isotope Market, by End User
1.4.3 LAMEA Medical Isotope Market, by Application
1.4.4 LAMEA Medical Isotope Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Medical Isotopes Market
Chapter 5. LAMEA Medical Isotope Market by Type
5.1 LAMEA Radioisotopes Market by Country
5.2 LAMEA Stable Isotopes Market by Country
Chapter 6. LAMEA Medical Isotope Market by End User
6.1 LAMEA Hospitals Market by Country
6.2 LAMEA Diagnostic Centers Market by Country
6.3 LAMEA Research Institutes Market by Country
Chapter 7. LAMEA Medical Isotope Market by Application
7.1 LAMEA Diagonostic Market by Country
7.2 LAMEA Nuclear Therapy Market by Country
Chapter 8. LAMEA Medical Isotope Market by Country
8.1 Brazil Medical Isotope Market
8.1.1 Brazil Medical Isotope Market by Type
8.1.2 Brazil Medical Isotope Market by End User
8.1.3 Brazil Medical Isotope Market by Application
8.2 Argentina Medical Isotope Market
8.2.1 Argentina Medical Isotope Market by Type
8.2.2 Argentina Medical Isotope Market by End User
8.2.3 Argentina Medical Isotope Market by Application
8.3 UAE Medical Isotope Market
8.3.1 UAE Medical Isotope Market by Type
8.3.2 UAE Medical Isotope Market by End User
8.3.3 UAE Medical Isotope Market by Application
8.4 Saudi Arabia Medical Isotope Market
8.4.1 Saudi Arabia Medical Isotope Market by Type
8.4.2 Saudi Arabia Medical Isotope Market by End User
8.4.3 Saudi Arabia Medical Isotope Market by Application
8.5 South Africa Medical Isotope Market
8.5.1 South Africa Medical Isotope Market by Type
8.5.2 South Africa Medical Isotope Market by End User
8.5.3 South Africa Medical Isotope Market by Application
8.6 Nigeria Medical Isotope Market
8.6.1 Nigeria Medical Isotope Market by Type
8.6.2 Nigeria Medical Isotope Market by End User
8.6.3 Nigeria Medical Isotope Market by Application
8.7 Rest of LAMEA Medical Isotope Market
8.7.1 Rest of LAMEA Medical Isotope Market by Type
8.7.2 Rest of LAMEA Medical Isotope Market by End User
8.7.3 Rest of LAMEA Medical Isotope Market by Application
Chapter 9. Company Profiles
9.1 Canadian Nuclear Laboratories (Atomic Energy of Canada Limited)
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.3 SWOT Analysis
9.2 ITM Isotope Technologies Munich SE
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.2.3 SWOT Analysis
9.3 ECZACIBAŞI-MONROL
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Partnerships, Collaborations, and Agreements:
9.3.3 SWOT Analysis
9.4 NorthStar Medical Radioisotopes, LLC
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.4.3 SWOT Analysis
9.5 Iba SA
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 Mallinckrodt PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 GE HealthCare Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Nordion Inc. (Sotera Health LLC)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.9 Bayer AG
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Siemens Healthineers AG (Siemens AG)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis
Unique Offerings 